The diagnosis and treatment of the montelukast to improve allergic purpura of children with kidney damage

张滟,王春华,王克,杨金玲
DOI: https://doi.org/10.3969/j.issn.1671-4695.2015.013.008
2015-01-01
Abstract:Objective To study the montelukast and improve the clinical efficacy and safety of renal damage in children with allergic pur-pura. Methods 50 cases of children with allergic purpura were randomly divided into two groups,experimental group 26 cases,control group 24 cases. These cases adopt regular treatment,the experimental group applied montelukast,the control group used low molecular heparin calcium. The urine trace albumin and beta 2 microglobulin changes and clinical therapeutic effect were compared of the two groups of children with different period. Results The urine trace albumin and beta 2 microglobulin level of the two groups of cases after treatment showed that the experimental group was significantly lower than the control group( P < 0. 01). Compared the clinical efficacy,the experimental group was significantly higher than the control group( P < 0. 05). Compared to the experimental group,the skin rash and symptoms disappear time to relieve time was signifi-cantly shorter than the control group( P < 0. 01). Conclusion Montelukast of HSP patients have significant therapeutic effect,can effectively reduce kidney damage in children,reduce the incidence of nephritis,fast relieve symptoms in children,effectively shorten the course.
What problem does this paper attempt to address?